FDA Issues Final Patient Instructions for Biological Product

FDA issued its final guidance on developing the content and format of patient Instructions for Use IFU for human prescription drug and biological products, as well as drug-led or biologic-led combination products submitted under a new drug application.

Related Keywords

, Human Factors , Eengineering Process , Prescribing Information , Legal , Government , Business , Fda , La , Biologics License Application , Uman Factors Engineering Process , Food And Drug Administration ,